FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044487353> ?p ?o ?g. }

• W3044487353 endingPage "9099" @default.
• W3044487353 startingPage "9083" @default.
• W3044487353 abstract "Rationale: Malignant ascites caused by cancer cells results in poor prognosis and short average survival time. No effective treatment is currently available for malignant ascites. In this study, the effects of lentinan (LNT)-functionalized selenium nanoparticles (Selene) on malignant ascites were evaluated. Furthermore, the mechanism of Selene targeting mitochondria of tumor cells were also investigated. Methods: Selene were synthesized and characterized by TEM, AFM and particle size analysis. The OVCAR-3 and EAC cells induced ascites models were used to evaluate the effects of Selene on malignant ascites. Proteomic analysis, immunofluorescence, TEM and ICP-MS were used to determine the location of Selene in tumor cells. Mitochondrial membrane potential, ROS, ATP content, and caspase-1/3 activity were detected to evaluate the effect of Selene on mitochondrial function and cell apoptosis. Immunofluorescence, Co-IP, pull-down, duolink, Western blot, and FPLC were used to investigate the pathway of Selene targeting mitochondria. Results: Selene could effectively inhibit ascites induced by OVCAR-3 and EAC cells. Selene was mainly located in the mitochondria of tumor cells and induced apoptosis of tumor cells. The LNT in Selene was involved in caveolae-mediated endocytosis through the interaction between toll-like receptor-4 (TLR4) and caveolin 1 (CAV1). Furthermore, the Selene in the endocytic vesicles could enter the mitochondria via the mitochondrial membrane fusion pathway, which was mediated by TLR4/TNF receptor associated factor 3 (TRAF3)/mitofusin-1 (MFN1) protein complex. Conclusion: Selene is a candidate anticancer drug for the treatment of malignant ascites. And TLR4/TRAF3/MFN1 may be a specific nano-drug delivery pathway that could target the mitochondria." @default.
• W3044487353 created "2020-07-29" @default.
• W3044487353 creator A5008599015 @default.
• W3044487353 creator A5009880286 @default.
• W3044487353 creator A5010247484 @default.
• W3044487353 creator A5013811376 @default.
• W3044487353 creator A5017379979 @default.
• W3044487353 creator A5020367775 @default.
• W3044487353 creator A5022802322 @default.
• W3044487353 creator A5034916569 @default.
• W3044487353 creator A5036813675 @default.
• W3044487353 creator A5042465345 @default.
• W3044487353 creator A5056636515 @default.
• W3044487353 creator A5065748896 @default.
• W3044487353 creator A5084027527 @default.
• W3044487353 creator A5085610505 @default.
• W3044487353 creator A5087948156 @default.
• W3044487353 creator A5090358446 @default.
• W3044487353 creator A5090932841 @default.
• W3044487353 date "2020-01-01" @default.
• W3044487353 modified "2023-10-12" @default.
• W3044487353 title "Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway" @default.
• W3044487353 cites W1842568537 @default.
• W3044487353 cites W1967257974 @default.
• W3044487353 cites W2003110090 @default.
• W3044487353 cites W2006869872 @default.
• W3044487353 cites W2010115856 @default.
• W3044487353 cites W2015704490 @default.
• W3044487353 cites W2020018716 @default.
• W3044487353 cites W2020851513 @default.
• W3044487353 cites W2024507331 @default.
• W3044487353 cites W2043685095 @default.
• W3044487353 cites W2058891784 @default.
• W3044487353 cites W2060274331 @default.
• W3044487353 cites W2083588261 @default.
• W3044487353 cites W2100816628 @default.
• W3044487353 cites W2108457871 @default.
• W3044487353 cites W2121080406 @default.
• W3044487353 cites W2139333712 @default.
• W3044487353 cites W2169122182 @default.
• W3044487353 cites W2271181793 @default.
• W3044487353 cites W2318049965 @default.
• W3044487353 cites W2327515900 @default.
• W3044487353 cites W2492726733 @default.
• W3044487353 cites W2516639828 @default.
• W3044487353 cites W2581248702 @default.
• W3044487353 cites W2581807542 @default.
• W3044487353 cites W2609924679 @default.
• W3044487353 cites W2728985030 @default.
• W3044487353 cites W2767361334 @default.
• W3044487353 cites W2784018550 @default.
• W3044487353 cites W2788640168 @default.
• W3044487353 cites W2788865560 @default.
• W3044487353 cites W2883624339 @default.
• W3044487353 cites W2886488254 @default.
• W3044487353 cites W2887344124 @default.
• W3044487353 cites W2889190684 @default.
• W3044487353 cites W2891782651 @default.
• W3044487353 cites W2900589767 @default.
• W3044487353 cites W2903119065 @default.
• W3044487353 cites W2906337806 @default.
• W3044487353 cites W2912396451 @default.
• W3044487353 cites W2924501099 @default.
• W3044487353 cites W2948841440 @default.
• W3044487353 cites W2973218109 @default.
• W3044487353 cites W2988014471 @default.
• W3044487353 cites W2993240892 @default.
• W3044487353 cites W4237441880 @default.
• W3044487353 doi "https://doi.org/10.7150/thno.46467" @default.
• W3044487353 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7415812" @default.
• W3044487353 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32802180" @default.
• W3044487353 hasPublicationYear "2020" @default.
• W3044487353 type Work @default.
• W3044487353 sameAs 3044487353 @default.
• W3044487353 citedByCount "37" @default.
• W3044487353 countsByYear W30444873532021 @default.
• W3044487353 countsByYear W30444873532022 @default.
• W3044487353 countsByYear W30444873532023 @default.
• W3044487353 crossrefType "journal-article" @default.
• W3044487353 hasAuthorship W3044487353A5008599015 @default.
• W3044487353 hasAuthorship W3044487353A5009880286 @default.
• W3044487353 hasAuthorship W3044487353A5010247484 @default.
• W3044487353 hasAuthorship W3044487353A5013811376 @default.
• W3044487353 hasAuthorship W3044487353A5017379979 @default.
• W3044487353 hasAuthorship W3044487353A5020367775 @default.
• W3044487353 hasAuthorship W3044487353A5022802322 @default.
• W3044487353 hasAuthorship W3044487353A5034916569 @default.
• W3044487353 hasAuthorship W3044487353A5036813675 @default.
• W3044487353 hasAuthorship W3044487353A5042465345 @default.
• W3044487353 hasAuthorship W3044487353A5056636515 @default.
• W3044487353 hasAuthorship W3044487353A5065748896 @default.
• W3044487353 hasAuthorship W3044487353A5084027527 @default.
• W3044487353 hasAuthorship W3044487353A5085610505 @default.
• W3044487353 hasAuthorship W3044487353A5087948156 @default.
• W3044487353 hasAuthorship W3044487353A5090358446 @default.
• W3044487353 hasAuthorship W3044487353A5090932841 @default.
• W3044487353 hasBestOaLocation W30444873531 @default.
• W3044487353 hasConcept C104317684 @default.

• next